Gabapentin for Cough in Cancer

Research output: Contribution to journalArticlepeer-review


Cough is a common problem among cancer patients, especially lung cancer patients. Gabapentin has been shown to be effective in reducing cough number and severity in patients with idiopathic refractory cough. The authors report here the successful use of gabapentin at usual doses to treat cough in cancer patients, including two with lung cancer, with minimal side effects. Gabapentin may be a useful addition to the symptom management toolbox for palliation of cancer symptoms.

Original languageEnglish (US)
Pages (from-to)195-197
Number of pages3
JournalJournal of Pain and Palliative Care Pharmacotherapy
Issue number3-4
StatePublished - Oct 2 2017


  • Cancer cough
  • central mechanism
  • cough
  • gabapentin

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)


Dive into the research topics of 'Gabapentin for Cough in Cancer'. Together they form a unique fingerprint.

Cite this